DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 01 · Volume 14 · January 1988 DOI: 10.1055/s-002-7731

1
Thomas, Duncan P.: Overview of Venous Thrombogenesis
9
Ofosu, Frederick A.; Gray, Elaine: Mechanisms of Action of Heparin: Applications to the Development of Derivatives of Heparin and Heparinoids with Antithrombotic Properties
18
Boneu, Bernard; Caranobe, Claudine; Cadroy, Yves; Dol, Frederique; Gabaig, Anne-Marie; Dupouy, Dominique; Sie, Pierre: Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit
28
Andrew, Maureen; Schmidt, Barbara: Use of Heparin in Newborn Infants
33
Buchanan, Michael R.: Mechanisms of Pathogenesis of Arterial Thrombosis: Potential Sites of Inhibition by Therapeutic Compounds
41
Turpie, Alexander G. G.: Clinical Studies: Evidence for Intervention with Specific Antiplatelet Drugs in Arterial Thromboembolism
50
Fuster, Valentin; Badimon, Lina; Badimon, Juan J.; Chesebro, James: Prevention of Thromboembolism Induced by Prosthetic Heart Valves
59
Hornstra, Gerard: Effect of Dietary Lipids on Arterial Thrombus Formation: Rationale for the Support of Drug Therapy by Diet
66
Bastida, Eva: The Metastatic Cascade: Potential Approaches for the Inhibition of Metastasis
73
D'Amore, Patricia A.: Antiangiogenesis as a Strategy for Antimetastasis
79
Talmadge, James E.; Black, Paul L.: Immunotherapy of Metastatic Disease
88
Rickles, Frederick R.; Hancock, Wayne W.; Edwards, Richard L.; Zacharski, Leo R.: Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment
95
Collen, Desire: Potential Approaches for Therapeutic Intervention of Thrombosis by Fibrinolytic Agents
100
Loskutoff, David J.: Type 1 Plasminogen Activator Inhibitor and Its Potential Influence on Thrombolytic Therapy
110
Gurewich, Victor: Pro-Urokinase: Physiochemical Properties and Promotion of Its Fibrinolytic Activity by Urokinase and by Tissue Plasminogen Activator with which It Has a Complementary Mechanism of Action
116
Levine, Mark N.; Hirsh, Jack: Clinical Use of Low Molecular Weight Heparins and Heparinoids
126
Rickles, Frederick R.; Hancock, Wayne W.: Antimetastatic Agents. II. Summary of the Interactions of Tumor Cells with Blood Coagulation Factors, Platelets, Fibrinolytic Factors, and Inflammatory Cells and Their Soluble Mediators: Potential for Therapeutic Interventions
133
Murano, Genesio; Bick, Rodger L.: Abstracts of Current Literature